Massive stroke drug registry tests recovery in 23,000 patients
NCT ID NCT06707987
Summary
This study observed how well a clot-dissolving drug called non-immunogenic staphylokinase works for patients having a stroke caused by a blood clot. It followed over 23,000 patients in real-world hospital settings to check the drug's safety and see how many people recovered with little to no disability 90 days after treatment. The goal was to gather more evidence on this treatment's effectiveness after it was approved for use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Federal Brain and Neurotechnology Center
Moscow, 117513, Russia
Conditions
Explore the condition pages connected to this study.